0001209191-23-029518.txt : 20230515 0001209191-23-029518.hdr.sgml : 20230515 20230515170100 ACCESSION NUMBER: 0001209191-23-029518 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230515 FILED AS OF DATE: 20230515 DATE AS OF CHANGE: 20230515 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sabella Lauren M CENTRAL INDEX KEY: 0001360928 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50865 FILM NUMBER: 23923960 MAIL ADDRESS: STREET 1: C/O ACORDA THERAPEUTICS STREET 2: 420 SAW MILL RIVER ROAD CITY: ARDSLEY STATE: NY ZIP: 10502 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MANNKIND CORP CENTRAL INDEX KEY: 0000899460 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133607736 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 CASPER STREET CITY: DANBURY STATE: CT ZIP: 06810 BUSINESS PHONE: 818-661-5000 MAIL ADDRESS: STREET 1: 1 CASPER STREET CITY: DANBURY STATE: CT ZIP: 06810 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-05-15 0 0000899460 MANNKIND CORP MNKD 0001360928 Sabella Lauren M 1 CASPER STREET DANBURY CT 06810 0 1 0 0 EVP Chief Operating Officer 0 Common Stock,$.01 par value 2023-05-15 4 A 0 14184 4.23 A 14184 D The securities were purchased through the Issuer's Market Price Stock Purchase Plan. The purchase was approved by the Company's Board of Directors on May 13, 2023. /s/Lauren M. Sabella 2023-05-15